Media Center

Study indicates enGenes Biotech’s Shiga Toxin B subunits useful as drug carriers in cancer therapy

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) has led a new study investigating potential...

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will present its latest technologies at the...

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will make its debut at the 5th Integrated...

enGenes Biotech offers development and manufacturing support services that are highly relevant to companies wishing to develop...

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will use the reconvened physical Chemspec Europe...

Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have collaborated with researchers...

Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have co-authored a new study that...

enGenes Biotech has developed a leading-edge platform for the customized production of recombinant proteins and plasmid DNA that can...

Vienna, Austria: – Recombinant protein specialist manufacturer enGenes Biotech GmbH (enGenes) will present its innovative decoupled...

enGenes -express achieves high yield SARS CoV-2 nucleocapsid protein expression News-ReleasesEnGenes Biotech GmbH August 26th 2021...